Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03355911
Other study ID # 2016-07Obs-CHRMT
Secondary ID
Status Completed
Phase N/A
First received November 23, 2017
Last updated December 4, 2017
Start date October 1, 2016
Est. completion date May 30, 2017

Study information

Verified date November 2017
Source Centre Hospitalier Régional Metz-Thionville
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the impact of preoperative corneal thickness on visual outcomes following Descemet's stripping endothelial keratoplasty (DSAEK) or Descemet membrane endothelial keratoplasty (DMEK)


Description:

Patients underwent DSAEK or DMEK for endothelial dysfunction, from October 2013 to November 2016. Patients aged > 18 years and with an indication for posterior lamellar graft surgery, such as Fuchs dystrophy, were included. Exclusion criteria included a history of penetrating keratoplasty in the study eye and a need for a penetrating keratoplasty following endothelial graft failure. Visual acuity, central corneal thickness (CCT) and graft thickness were measured preoperatively, and at postoperative day 7 and months 1, 3 and 6.


Recruitment information / eligibility

Status Completed
Enrollment 113
Est. completion date May 30, 2017
Est. primary completion date May 30, 2017
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Clinically indicated need for posterior lamellar graft surgery (DSAEK or DMEK) such as:

- Fuchs dystrophy,

- pseudophakic bullous decompensation

- or other endothelial dysfunction corneal

Exclusion Criteria:

- were a history of penetrating keratoplasty in the indicated eye

- the technical inability of preoperative CCT measurement

- the need for a penetrating keratoplasty following endothelial graft failure

- severe postoperative complications resulting in unquantifiable visual acuity

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Régional Metz-Thionville

Outcome

Type Measure Description Time frame Safety issue
Primary Descemet's stripping endothelial keratoplasty (DSAEK) or Descemet membrane endothelial keratoplasty (DMEK) LogMar month 6